Cargando…

The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis

AIMS: Optimal medical therapy after cardiac resynchronization therapy (CRT) implantation is important in heart failure (HF) with reduced ejection fraction (HFrEF) patients. Although sacubitril/valsartan (SV) is a mainstay in the treatment of HFrEF, its efficacy in the management of CRT non‐responder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chun, Kyeong‐Hyeon, Oh, Jaewon, Yu, Hee Tae, Lee, Chan Joo, Kim, Tae‐Hoon, Uhm, Jae Sun, Pak, Hui‐Nam, Lee, Moon‐Hyoung, Joung, Boyoung, Kang, Seok‐Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755012/ https://www.ncbi.nlm.nih.gov/pubmed/32918402 http://dx.doi.org/10.1002/ehf2.12988

Ejemplares similares

Clinical Implications of Device-Detected Atrial Fibrillation in Cardiac Resynchronization Therapy
por: Yoon, Minjae, et al.
Publicado: (2023)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
por: Lee, Seonhwa, et al.
Publicado: (2020)

Left Ventricular End-Systolic Volume Can Predict 1-Year Hierarchical Clinical Composite End Point in Patients with Cardiac Resynchronization Therapy
por: Uhm, Jae-Sun, et al.
Publicado: (2019)

Clinical evidence of initiating a very low dose of sacubitril/valsartan: a prospective observational analysis
por: Kim, Hyoeun, et al.
Publicado: (2021)

Improvement in quality of life with sacubitril/valsartan in cardiac resynchronization non-responders: The RESINA (RESynchronization plus an Inhibitor of Neprilysin/Angiotensin) registry
por: Campal, José Manuel Rubio, et al.
Publicado: (2021)

Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy
por: Huang, Hsin‐Ti, et al.
Publicado: (2022)

Left ventricular response after cardiac resynchronization therapy is related to early left atrial volume reduction
por: Cho, In-Jeong, et al.
Publicado: (2020)

Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
por: Martín‐Garcia, Ana, et al.
Publicado: (2020)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
por: Vergaro, Giuseppe, et al.
Publicado: (2020)

Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes
por: Chun, Kyeong‐Hyeon, et al.
Publicado: (2022)

Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021)

Effect of epicardial fat volume on outcomes after left atrial posterior wall isolation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation
por: Kim, Daehoon, et al.
Publicado: (2022)

Corrigendum: Effect of epicardial fat volume on outcomes after left atrial posterior wall isolation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation
por: Kim, Daehoon, et al.
Publicado: (2023)

Intraatrial reentrant tachycardia originating from the prior suture line of the baffle in a patient who underwent the Mustard operation: Ultra-high-density 3-dimensional mapping
por: Uhm, Jae-Sun, et al.
Publicado: (2018)

Risk Factors for Stiff Left Atrial Physiology 1 Year After Catheter Ablation of Atrial Fibrillation
por: Lee, Jae-Hyuk, et al.
Publicado: (2021)

Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction
por: Yang, Pei, et al.
Publicado: (2023)

Sacubitril/valsartan in patients listed for heart transplantation: effect on physical frailty
por: Cacciatore, Francesco, et al.
Publicado: (2020)

Does Additional Electrogram‐Guided Ablation After Linear Ablation Reduce Recurrence After Catheter Ablation for Longstanding Persistent Atrial Fibrillation? A Prospective Randomized Study
por: Kim, Tae‐Hoon, et al.
Publicado: (2017)

One-Year Change in the H(2)FPEF Score After Catheter Ablation of Atrial Fibrillation in Patients With a Normal Left Ventricular Systolic Function
por: Kim, Min, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic and Public Restrictions on Outcomes After Catheter Ablation of Atrial Fibrillation
por: Kim, Daehoon, et al.
Publicado: (2022)

Effectiveness and safety of single transseptal ablation for atrial fibrillation in real‐word practice
por: Park, Yoon Jung, et al.
Publicado: (2021)

Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016)

The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data
por: Lee, Hancheol, et al.
Publicado: (2017)

Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
por: Kim, Kyu, et al.
Publicado: (2018)

Various triggers of phase 4 block
por: Uhm, Jae-Sun, et al.
Publicado: (2018)

High Prevalence and Clinical Implication of Myocardial Bridging in Patients with Early Repolarization
por: Seo, Jiwon, et al.
Publicado: (2017)

Lower pulmonary vein-to-left atrium volume ratio predicts poor rhythm outcome after atrial fibrillation catheter ablation
por: Lee, Jae-Hyuk, et al.
Publicado: (2022)

Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation
por: Kim, Tae‐Hoon, et al.
Publicado: (2016)

CHA(2)DS(2)-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter
por: Jin, Moo-Nyun, et al.
Publicado: (2018)

Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study
por: Lee, Hye Young, et al.
Publicado: (2017)

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients
por: Oh, Ji‐Hye, et al.
Publicado: (2022)

Restitution Slope Affects the Outcome of Dominant Frequency Ablation in Persistent Atrial Fibrillation: CUVIA-AF2 Post-Hoc Analysis Based on Computational Modeling Study
por: Park, Je-Wook, et al.
Publicado: (2022)

Real-World Usage of Sacubitril/Valsartan in Korea: A Multi-Center, Retrospective Study
por: Park, Jin Joo, et al.
Publicado: (2022)

Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)

Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)

Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
por: Tolomeo, Paolo, et al.
Publicado: (2022)

Permanent Pacemaker Implantations after Catheter Ablation in Patients with Atrial Fibrillation Associated with Underlying Sinus Node Dysfunction
por: Hwang, Tae Hyun, et al.
Publicado: (2019)

Persistent atrial fibrillation over 3 years is associated with higher recurrence after catheter ablation
por: Yu, Hee Tae, et al.
Publicado: (2020)

Case Report: Delayed Ventricular Pseudoaneurysm After Radiofrequency Ablation of Left Posteromedial Papillary Muscle Ventricular Tachycardia
por: Kim, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mlcg42mqsr89vr67cgo508j066